Evicenter
P&T meetings

SL1009 (sodium dichloroacetate)

Pyruvate dehydrogenase complex deficiency

Manufacturer
Saol Therapeutics
Regulatory submission
NDA resubmitted June 2026
Launch
Not announced
Last updated
78 sources

Clinical evidence

Oral dichloroacetate in chronic congenital lactic acidosis

5 evidence topics · 1 source

Objective
Location and study date

No evidence found.

Study design
Eligibility criteria

No evidence found.

Treatment
Study outcomes
Rationale for using blood lactate as a biochemical outcome

Not applicable.

Statistical analysis description
Number of participants (Planned and analyzed)
Description of analysis sets

Not applicable.

Results
Participant disposition

No evidence found.

Baseline characteristics
Efficacy results
Health-related quality of life and patient-reported outcomes

No evidence found.

Safety results
Study limitations
Summary

The report describes two participants of different ages, without a randomized comparator. Reduced blood lactate in the first participant is a biochemical observation, not evidence of a general clinical treatment effect. Reported drug accumulation limits interpretation of biochemical response without considering exposure and toxicity.